Alizé Pharma
Latest round
- Series A
Last raised
- Jul 2019
Total raised
- $75M
Investors
- 8
About Alizé Pharma
Established in 2007 and based in Ecully, France, Alizé Pharma operates as a biotechnology company that focuses on developing therapeutic peptides for the treatment of rare endocrine and metabolic diseases.
Who invested in Alizé Pharma
8 investors across 1 round
See all investors in Alizé Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 31, 2019
Amount
$75M
Investors
Questions about Alizé Pharma
Who invested in Alizé Pharma?
Alizé Pharma has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alizé Pharma raised?
Alizé Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alizé Pharma last raise money?
Alizé Pharma's most recent round on record is a Series A, in Jul 2019.
What does Alizé Pharma do?
Established in 2007 and based in Ecully, France, Alizé Pharma operates as a biotechnology company that focuses on developing therapeutic peptides for the treatment of rare endocrine and metabolic diseases.
Where is Alizé Pharma headquartered?
Alizé Pharma is headquartered in France.
Which VCs invest in companies like Alizé Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Alizé Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Alizé Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.